Researchers Identify Best Drug Therapy for Rare, Aggressive, Pancreatic Cancer
JACKSONVILLE, Fla. — Each year, about 200 to 400 Americans develop pancreatic acinar cell carcinoma, a rare form of pancreatic cancer that has no effective standard of care. A study involving researchers on Mayo Clinic’s Florida and Rochester campuses has found that the chemotherapy drug oxaliplatin is effective in stopping the growth of this cancer. [...]
Source: Mayo Clinic Research News - Category: Research Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Eloxatin | Pancreas | Pancreatic Cancer | Research | Study